Studies have shown that maternal vaccination against pertussis during pregnancy results in a GMC of Anti-PT-lgG >30 IU/mL in newborns at birth [33].The results of this study showed a significant increase in Anti-PT-lgG levels with the number of vaccine doses administered. The gene discussed is F2; the disease is pertussis.